Jelena Vojicic, MD

Vaccines Medical Lead
Pfizer Canada, Canada

Disclosure(s): Pfizer Inc.: Employee, Stocks/Bonds (Public Company), Stocks/Bonds (Public Company)

Poster(s):

• (P-654) Demographic and Clinical Characteristics, by Pneumococcal Serotype, of Adults Hospitalized with Community Acquired Pneumonia in the United States
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-679) Invasive pneumococcal pneumonia: is bacteremia the appropriate indication of severity?
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-1428) Real-World Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine among Adults 65-74, 75-84, and ≥85 Years of Age in the United States
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1456) Re-evaluating Economic & Health Impact of PCV20 in Adults Using Real-world Effectiveness Data
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET